FIELD: medicine, hematology.
SUBSTANCE: invention relates to development of novel fields in investigation of blood clot fibrin. Method involves dissolving fibrin isolated from human or animals blood clot in 18-22.5% sodium chloride solution and incubation at temperature 37-38°C for 18-24 h. Prepared fractions are separated in dividing funnel and fibrin physiological solution is prepared by addition of the corresponding amount of distilled water. Invention provides preparing fibrin fraction without using sodium hydroxide but by using neutral salt followed by addition of distilled water up to preparing fibrin fractions in sodium chloride physiological solution.
EFFECT: improved separation method of fibrin.
1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF FIBRIN FRACTION PREPARING | 1991 |
|
RU2056848C1 |
| METHOD FOR PRODUCTION OF HEMINE | 1991 |
|
RU2045267C1 |
| PROCESS FOR MANUFACTURE OF FIBROUS FIBRIN | 1991 |
|
RU2032411C1 |
| METHOD OF FIBRIN PHYSIOLOGICAL SOLUTION PREPARING | 1992 |
|
RU2082410C1 |
| METHOD OF PREPARING ANTICARCINOMA SERUM | 1991 |
|
RU2009502C1 |
| METHOD OF RECEPTION OF HEMIN | 2008 |
|
RU2359682C1 |
| METHOD FOR PREPARATION OF FIBRINOUS FOAM | 1991 |
|
RU2033167C1 |
| METHOD OF PREPARING WATER-SOLUBLE FIBRIN POWDER | 1992 |
|
RU2057535C1 |
| METHOD OF DETECTION OF CANCER ILLNESS RISK | 1992 |
|
RU2069859C1 |
| METHOD FOR PRODUCING BONDING PASTE | 2014 |
|
RU2561676C1 |
